Close
Close
Game-changing drug classes for multiple myeloma
393 views
3.18181818182
3.2 from 11 votes

Multiple myeloma is a cancer of plasma cells, a type of white blood cell normally responsible for producing antibodies. In multiple myeloma, collections of abnormal plasma cells accumulate in the bone marrow, where they interfere with the production of normal blood cells. Most cases of multiple myeloma also feature the production of a paraprotein—an abnormal antibody which can cause kidney problems. Bone lesions and hypercalcemia (high blood calcium levels) are also often encountered.

Multiple myeloma is diagnosed with blood tests (serum protein electrophoresis, serum free kappa/lambda light chain assay), bone marrow examination, urine protein electrophoresis, and X-rays of commonly involved bones.

Multiple myeloma is considered to be incurable but treatable. Remissions may be induced with steroids, chemotherapy, proteasome inhibitors, immunomodulatory drugs such as thalidomide or lenalidomide, and stem cell transplants. Radiation therapy is sometimes used to reduce pain from bone lesions.

Learn more about:

Access Programs

by Abidemi Uruejoma
11 views 6 days ago
by Abidemi Uruejoma
45 views 1 month ago
by Abidemi Uruejoma
63 views 1 month ago
by Abidemi Uruejoma
68 views 1 month ago
by Abidemi Uruejoma
91 views 2 months ago
by Abidemi Uruejoma
94 views 2 months ago
by Abidemi Uruejoma
99 views 2 months ago
by Abidemi Uruejoma
107 views 2 months ago
by Abidemi Uruejoma
99 views 2 months ago
3.18181818182
3.2 from 11 votes
Free Newsletter
Find a Clinical Trial
Related Videos
News Articles